AllAnalyst Report
Morningstar•July 29, 2021
Morningstar•July 29, 2021Stericycle, Inc.: We’ve Upgraded Stericycle’s Moat Rating To Narrow As Turnaround Efforts Gain Traction
Summary
Stericycle is the largest provider of medical waste disposal and data destruction (primarily paper shredding) services in the United States. Its next closest national competitor in the medical waste disposal space is Sharps Compliance, which generated $51 million of sales in 2020 (about 3% of Stericycle's global regulated waste and compliance revenue). Stericycle's data destruction business (Shred-It) is about twice the size of its closest competitor (Iron Mountain's information destruction segment). Stericycle h
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeActions
Download Full ReportRelated Reports
- CLH: Raising target price to $211.00Apr 24, 2024 •
CLH
- EXPD: Lowering target price to $119.00Apr 24, 2024 •
EXPD
- CHRW: Raising target price to $74.00Apr 24, 2024 •
CHRW
- SEE: What does Argus have to say about SEE?Apr 24, 2024 •
SEE
- WAT: What does Argus have to say about WAT?Apr 24, 2024 •
WAT
Analyst Profile
Brian Bernard
Sector DirectorBrian Colello, CPA, is director of technology, media, and telecom equity research for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. In addition to leading Morningstar’s technology, media, and telecom sector team, he covers semiconductor and hardware companies. Colello was a senior equity analyst before assuming his current role in 2015.Before joining Morningstar in 2008, he worked in public accounting for KPMG and served as a manager in corporate finance for BMG Music, a subsidiary of Bertelsmann AG.Colello holds a bachelor’s degree in accounting from Bucknell University and a master’s degree in business administration from Wake Forest. He is also a Certified Public Accountant.